A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Clinical trial NCT02218372 · COMPLETED
Trial details
- NCT number
- NCT02218372
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-09
- Primary completion
- 2018-03-07
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.